
AI-driven radiomics and radiogenomics: supporting the assessment and differentiation of pseudoprogression in cellular immunotherapy for glioblastoma
<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxQVkRJTlBEcXRqcGdWQUdhRFhIdE1UM202NVFYLWUtTlBMd1kwREEzdWRhNk5aS0JXV0VPNVJYMmxkd2wzdlMxVHMxM29JSnhYTi1KMHFhYVVaU21NQ1NDVXliMVI1ZW95MS1PNnppam5KcWM0WVRPeXBDd1JNZUJzazdqRWlPLVptTTI5TUduTlZidw?oc=5" target="_blank">AI-driven radiomics and radiogenomics: supporting the assessment and differentiation of pseudoprogression in cellular immunotherapy for glioblastoma</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
